Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 236

1.

Autocrine stimulation of VEGFR-2 activates human leukemic cell growth and migration.

Dias S, Hattori K, Zhu Z, Heissig B, Choy M, Lane W, Wu Y, Chadburn A, Hyjek E, Gill M, Hicklin DJ, Witte L, Moore MA, Rafii S.

J Clin Invest. 2000 Aug;106(4):511-21.

PMID:
10953026
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Inhibition of both paracrine and autocrine VEGF/ VEGFR-2 signaling pathways is essential to induce long-term remission of xenotransplanted human leukemias.

Dias S, Hattori K, Heissig B, Zhu Z, Wu Y, Witte L, Hicklin DJ, Tateno M, Bohlen P, Moore MA, Rafii S.

Proc Natl Acad Sci U S A. 2001 Sep 11;98(19):10857-62.

PMID:
11553814
[PubMed - indexed for MEDLINE]
Free PMC Article
3.
4.

VEGF(165) promotes survival of leukemic cells by Hsp90-mediated induction of Bcl-2 expression and apoptosis inhibition.

Dias S, Shmelkov SV, Lam G, Rafii S.

Blood. 2002 Apr 1;99(7):2532-40.

PMID:
11895790
[PubMed - indexed for MEDLINE]
Free Article
5.

The protein tyrosine kinase inhibitor SU5614 inhibits VEGF-induced endothelial cell sprouting and induces growth arrest and apoptosis by inhibition of c-kit in AML cells.

Spiekermann K, Faber F, Voswinckel R, Hiddemann W.

Exp Hematol. 2002 Jul;30(7):767-73.

PMID:
12135675
[PubMed - indexed for MEDLINE]
6.

Vascular endothelial growth factor: acting as an autocrine growth factor for human gastric adenocarcinoma cell MGC803.

Tian X, Song S, Wu J, Meng L, Dong Z, Shou C.

Biochem Biophys Res Commun. 2001 Aug 24;286(3):505-12.

PMID:
11511087
[PubMed - indexed for MEDLINE]
7.

Treatment for malignant pleural effusion of human lung adenocarcinoma by inhibition of vascular endothelial growth factor receptor tyrosine kinase phosphorylation.

Yano S, Herbst RS, Shinohara H, Knighton B, Bucana CD, Killion JJ, Wood J, Fidler IJ.

Clin Cancer Res. 2000 Mar;6(3):957-65.

PMID:
10741721
[PubMed - indexed for MEDLINE]
Free Article
8.

VEGF regulates haematopoietic stem cell survival by an internal autocrine loop mechanism.

Gerber HP, Malik AK, Solar GP, Sherman D, Liang XH, Meng G, Hong K, Marsters JC, Ferrara N.

Nature. 2002 Jun 27;417(6892):954-8.

PMID:
12087404
[PubMed - indexed for MEDLINE]
9.

Expression and functional significance of vascular endothelial growth factor receptors in human tumor cells.

Herold-Mende C, Steiner HH, Andl T, Riede D, Buttler A, Reisser C, Fusenig NE, Mueller MM.

Lab Invest. 1999 Dec;79(12):1573-82.

PMID:
10616207
[PubMed - indexed for MEDLINE]
10.

Increased vascular endothelial growth factor 165 binding to kinase insert domain-containing receptor after infection of human endothelial cells by recombinant adenovirus encoding the Vegf(165) gene.

Weisz A, Koren B, Cohen T, Neufeld G, Kleinberger T, Lewis BS, Flugelman MY.

Circulation. 2001 Apr 10;103(14):1887-92.

PMID:
11294808
[PubMed - indexed for MEDLINE]
Free Article
11.

Up-regulation of flk-1/vascular endothelial growth factor receptor 2 by its ligand in a cerebral slice culture system.

Kremer C, Breier G, Risau W, Plate KH.

Cancer Res. 1997 Sep 1;57(17):3852-9.

PMID:
9288799
[PubMed - indexed for MEDLINE]
Free Article
12.

Vascular endothelial growth factor (VEGF) is an autocrine growth factor for VEGF receptor-positive human tumors.

Masood R, Cai J, Zheng T, Smith DL, Hinton DR, Gill PS.

Blood. 2001 Sep 15;98(6):1904-13.

PMID:
11535528
[PubMed - indexed for MEDLINE]
Free Article
13.

Increased renal expression of vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 in experimental diabetes.

Cooper ME, Vranes D, Youssef S, Stacker SA, Cox AJ, Rizkalla B, Casley DJ, Bach LA, Kelly DJ, Gilbert RE.

Diabetes. 1999 Nov;48(11):2229-39.

PMID:
10535459
[PubMed - indexed for MEDLINE]
15.

Vascular endothelial growth factor (VEGF) in cartilage neovascularization and chondrocyte differentiation: auto-paracrine role during endochondral bone formation.

Carlevaro MF, Cermelli S, Cancedda R, Descalzi Cancedda F.

J Cell Sci. 2000 Jan;113 ( Pt 1):59-69.

PMID:
10591625
[PubMed - indexed for MEDLINE]
Free Article
16.

Vascular endothelial growth factor is an in vivo survival factor for tumor endothelium in a murine model of colorectal carcinoma liver metastases.

Bruns CJ, Liu W, Davis DW, Shaheen RM, McConkey DJ, Wilson MR, Bucana CD, Hicklin DJ, Ellis LM.

Cancer. 2000 Aug 1;89(3):488-99.

PMID:
10931447
[PubMed - indexed for MEDLINE]
18.

Inhibition of human leukemia in an animal model with human antibodies directed against vascular endothelial growth factor receptor 2. Correlation between antibody affinity and biological activity.

Zhu Z, Hattori K, Zhang H, Jimenez X, Ludwig DL, Dias S, Kussie P, Koo H, Kim HJ, Lu D, Liu M, Tejada R, Friedrich M, Bohlen P, Witte L, Rafii S.

Leukemia. 2003 Mar;17(3):604-11.

PMID:
12646950
[PubMed - indexed for MEDLINE]
19.

The splice variants of vascular endothelial growth factor (VEGF) and their receptors.

Robinson CJ, Stringer SE.

J Cell Sci. 2001 Mar;114(Pt 5):853-65. Review.

PMID:
11181169
[PubMed - indexed for MEDLINE]
Free Article
20.

Suppression of tumor lymphangiogenesis and lymph node metastasis by blocking vascular endothelial growth factor receptor 3 signaling.

He Y, Kozaki K, Karpanen T, Koshikawa K, Yla-Herttuala S, Takahashi T, Alitalo K.

J Natl Cancer Inst. 2002 Jun 5;94(11):819-25.

PMID:
12048269
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk